
Biotechnology · NSE
Sheel Biotech Limited, incorporated in November 1991, specializes in biotechnology, floriculture, greenhouses, and organic farming. The company produces high-quality, disease-free plants for fruits, vegetables, ornamentals, and field crops using tissue culture and hydroponics, and provides greenhouse manufacturing, farmer services, and training through FPOs. It also offers landscaping services to government and private clients and holds ISO certifications for quality, environment, and safety. Its R&D lab is recognized by India’s Department of Biotechnology and Department of Science and Technology. Sheel Biotech supports organic farming adoption, manages FPOs, implements turnkey horticultural projects with modern technologies, and conducts training programs for farmers and agripreneurs. As of September 30, 2024, it had 160 permanent employees.
Price Band
₹59 – ₹63
Issue Size
₹34.02 Cr
Lot Size
2000 shares
GMP
+23.8%
Est. Listing
₹78
at current GMP
Subscribed
16.05x
overall
Open
30 Sep 2025
Close
3 Oct 2025
Allotment
6 Oct 2025
Refund
7 Oct 2025
Demat Credit
8 Oct 2025
Listing
8 Oct 2025
Overall Subscription
16.05x
Total Demand
QIB Multiplier
19.73x
Institutions & Funds
NII / HNI
26.29x
High Net-Worth
Retail (RII)
9.57x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 1,026,000 | 20,244,000 | 19.73x |
| NIB | 774,000 | 20,352,000 | 26.29x |
| HNIs(10L +) | 516,000 | 16,596,000 | 32.16x |
| HNIs (2-10L) | 258,000 | 3,756,000 | 14.56x |
| RETAIL | 1,804,000 | 17,260,000 | 9.57x |
| Total | 4,378,000 | 78,208,000 | 16.05x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 18 | 0.00x |
| NIB | — | 1,363 | 0.00x |
| RETAIL | 451 | 4,315 | 9.57x |
| HNIs(10L +) | 86 | 761 | 8.85x |
| HNIs (2-10L) | 43 | 602 | 14.00x |
| Total Applications | 580 | 7,059 | 12.17x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Sheel Biotech Limited is bringing an initial public offering (IPO) in the Biotechnology sector with an aggregate issue size of ₹34.02 Crores. The shares are offered at a price band of ₹59 to ₹63 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 2000 shares (approx. ₹1,26,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Skyline Financial Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-10-08, while un-allotted funds or UPI block mandates will be released on 2025-10-07.
The latest Grey Market Premium (GMP) for Sheel Biotech Limited IPO is ₹15 per equity share. Based on the upper price band of ₹59 to ₹63 per equity share, the estimated listing price is ₹78 (+23.8% expected listing gain).
With a lot size of 2000 shares and current GMP of ₹15, the expected profit per application lot is approx ₹30,000 (+23.8% gain). Minimum application cost is approx ₹1,26,000.
The Sheel Biotech Limited IPO aggregate issue size is ₹34.02 Crores with an equity price band set at ₹59 to ₹63 per equity share. The retail lot size is 2000 shares requiring a minimum capital outlay of approx. ₹1,26,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 16.05x (Retail: 9.57x, QIB: 19.73x, NII: 26.29x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Skyline Financial Services Private Limited) and the BSE status verification website on or around 2025-10-06. Investors can verify status using PAN card or application number.
Sheel Biotech Limited shares are scheduled to list on NSE on 2025-10-08.